Releasing the U.S. Senate Health, Education, Labor, and Pensions Committee's findings on the prices of weight loss drugs in the United States, Sen. Bernie Sanders on Wednesday ramped up pressure on a Danish pharmaceutical company to lower the 'outrageously high' prices of Ozempic and Wegovy, warning that the current pricing could bankrupt the country's healthcare system.
'The report cites the North Carolina state health plan's decision last month to end coverage for Wegovy and similar medications. The plan administrators 'estimated that continuing coverage for Wegovy at its current price would require them to double insurance premiums. Faced with impossible choices, the health plan eliminated coverage,' reads the report.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: